Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Polycystic ovary syndrome|
|Citation:||The Lancet, 2007; 370(9588):685-697|
|Robert J Norman, Didier Dewailly, Richard S Legro and Theresa E Hickey|
|Abstract:||Polycystic ovary syndrome is a heterogeneous endocrine disorder that affects about one in 15 women worldwide. The major endocrine disruption is excessive androgen secretion or activity, and a large proportion of women also have abnormal insulin activity. Many body systems are affected in polycystic ovary syndrome, resulting in several health complications, including menstrual dysfunction, infertility, hirsutism, acne, obesity, and metabolic syndrome. Women with this disorder have an established increased risk of developing type 2 diabetes and a still debated increased risk of cardiovascular disease. The diagnostic traits of polycystic ovary syndrome are hyperandrogenism, chronic anovulation, and polycystic ovaries, after exclusion of other conditions that cause these same features. A conclusive definition of the disorder and the importance of the three diagnostic criteria relative to each other remain controversial. The cause of polycystic ovary syndrome is unknown, but studies suggest a strong genetic component that is affected by gestational environment, lifestyle factors, or both.|
Polycystic Ovary Syndrome
|Description:||Copyright © 2007 Elsevier Ltd All rights reserved.|
|Appears in Collections:||Aurora harvest 6|
Obstetrics and Gynaecology publications
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.